Header cover image

Investing Ideas
/
Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Indian Pharmaceuticals & Biotech Strong Past Earnings Growth, P/E Ratio Below 20

Results

8

4 new

A list of companies that grew earnings by 20% and are trading on less than 20 times earnings. All with a debt to equity ratio below 1.

8 companies

	Company	Last Price	7D Return	1Y Return	Market Cap	Analysts Target	Valuation	Growth	Div Yield
	531633 Lincoln Pharmaceuticals	₹614.35	-9.7%	2.9%	₹12.5b	n/a	PE12.6x	n/a	0.3%
	506260 Anuh Pharma	₹193.00	-3.8%	21.3%	₹9.5b	n/a	PE16.4x	n/a	1.3%
	524075 Albert David	₹1,335.50	-1.4%	45.4%	₹7.6b	n/a	PE10.8x	n/a	0.9%
	524731 New Jenburkt Pharmaceuticals	₹1,197.10	-8.3%	74.9%	₹5.0b	n/a	PE17.4x	n/a	1.3%
	PAR New Par Drugs and Chemicals	₹271.10	-9.4%	13.6%	₹3.3b	n/a	PE18.3x	n/a	0%
	ALPA Alpa Laboratories	₹108.54	-3.8%	11.2%	₹2.3b	n/a	PE14.1x	n/a	n/a
	524828 New BDH Industries	₹307.40	-5.4%	65.7%	₹1.8b	n/a	PE18.2x	n/a	1.5%
	530233 New Auro Laboratories	₹199.00	-21.6%	42.4%	₹1.3b	n/a	PE19.9x	n/a	n/a

Page 1 of 1